650 related articles for article (PubMed ID: 23416279)
1. Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.
Anand N; Sampath K; Wu BU
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):913-21; quiz e59-60. PubMed ID: 23416279
[TBL] [Abstract][Full Text] [Related]
2. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
[TBL] [Abstract][Full Text] [Related]
3. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Nagai K; Doi R; Ito T; Kida A; Koizumi M; Masui T; Kawaguchi Y; Ogawa K; Uemoto S
J Hepatobiliary Pancreat Surg; 2009; 16(3):353-8. PubMed ID: 19280108
[TBL] [Abstract][Full Text] [Related]
4. Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.
Kim KW; Park SH; Pyo J; Yoon SH; Byun JH; Lee MG; Krajewski KM; Ramaiya NH
Ann Surg; 2014 Jan; 259(1):72-81. PubMed ID: 23657084
[TBL] [Abstract][Full Text] [Related]
5. Predictors of malignancy in pure branch duct type intraductal papillary mucinous neoplasm of the pancreas: A nationwide multicenter study.
Kim TH; Song TJ; Hwang JH; Yoo KS; Lee WJ; Lee KH; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Kim EY; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Oh DW; Kim MH
Pancreatology; 2015; 15(4):405-10. PubMed ID: 25998516
[TBL] [Abstract][Full Text] [Related]
6. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC
Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480
[TBL] [Abstract][Full Text] [Related]
7. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
8. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus.
Tanaka M
Digestion; 2014; 90(4):265-72. PubMed ID: 25591885
[TBL] [Abstract][Full Text] [Related]
9. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
[TBL] [Abstract][Full Text] [Related]
10. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
[TBL] [Abstract][Full Text] [Related]
11. Intraductal papillary mucinous neoplasms of the pancreas.
Gourgiotis S; Ridolfini MP; Germanos S
Eur J Surg Oncol; 2007 Aug; 33(6):678-84. PubMed ID: 17207960
[TBL] [Abstract][Full Text] [Related]
12. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Malignancy in "Pure" Branch-Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Enhancing Mural Nodules on CT Imaging: A Nationwide Multicenter Study.
Kim TH; Woo YS; Chon HK; Hwang JH; Yoo KS; Lee WJ; Lee KH; Lee JK; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Park JW; Kim MH
Gut Liver; 2018 Sep; 12(5):583-590. PubMed ID: 29730906
[TBL] [Abstract][Full Text] [Related]
14. Appropriate indications of initial endoscopic ultrasound evaluation for detecting mural nodules in branch duct intraductal papillary mucinous neoplasms of the pancreas.
Kim YI; Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Hong EK
Scand J Gastroenterol; 2013 May; 48(5):610-6. PubMed ID: 23597152
[TBL] [Abstract][Full Text] [Related]
15. An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas.
Ohtsuka T; Kono H; Nagayoshi Y; Mori Y; Tsutsumi K; Sadakari Y; Takahata S; Morimatsu K; Aishima S; Igarashi H; Ito T; Ishigami K; Nakamura M; Mizumoto K; Tanaka M
Surgery; 2012 Jan; 151(1):76-83. PubMed ID: 21875733
[TBL] [Abstract][Full Text] [Related]
16. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
[TBL] [Abstract][Full Text] [Related]
17. Morphologic changes in branch duct intraductal papillary mucinous neoplasms of the pancreas: a midterm follow-up study.
Rautou PE; Lévy P; Vullierme MP; O'Toole D; Couvelard A; Cazals-Hatem D; Palazzo L; Aubert A; Sauvanet A; Hammel P; Hentic O; Rebours V; Pelletier AL; Maire F; Ruszniewski P
Clin Gastroenterol Hepatol; 2008 Jul; 6(7):807-14. PubMed ID: 18304885
[TBL] [Abstract][Full Text] [Related]
18. Predictors of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas.
Kawada N; Uehara H; Nagata S; Tsuchishima M; Tsutsumi M; Tomita Y
JOP; 2014 Sep; 15(5):459-64. PubMed ID: 25262713
[TBL] [Abstract][Full Text] [Related]
19. [Presentation, treatment and prognosis of intraductal papillary mucinous neoplasm].
Ridolfini MP; Gourgiotis S; Alfieri S; Di Miceli D; Rotondi F; Limongelli F; Quero G; Larghi A; Cazzato MT; Martella N; Doglietto GB
Ann Ital Chir; 2007; 78(4):257-64. PubMed ID: 17990599
[TBL] [Abstract][Full Text] [Related]
20. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe?
Jang JY; Kim SW; Lee SE; Yang SH; Lee KU; Lee YJ; Kim SC; Han DJ; Choi DW; Choi SH; Heo JS; Cho BH; Yu HC; Yoon DS; Lee WJ; Lee HE; Kang GH; Lee JM
Ann Surg Oncol; 2008 Jan; 15(1):199-205. PubMed ID: 17909912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
